학술논문

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Document Type
Article
Source
In The Lancet Oncology November 2015 16(15):1473-1482
Subject
Primary Research
Articles
Language
ISSN
1470-2045